Comparison study of gastrinomas between gastric and non-gastric origins

Huang, Song-Fong; Kuo, I-Ming; Lee, Chao-Wei; Pan, Kuang-Tse; Chen, Tse-Ching; Lin, Chun-Jung; Hwang, Tsann-Long; Yu, Ming-Chin

doi:10.1186/s12957-015-0614-6

World Journal of Surgical Oncology

Table 1 Personal characteristic data of twenty cases with gastrinoma

From: Comparison study of gastrinomas between gastric and non-gastric origins

Case no.	Age	Gender	Clinical presentation	Primary site	WHO grading	Gastrin (pg/ml)	Procedure	Tumor size (mm)	Outcome	F/u period (months)	LN meta	Liver meta	Other meta	Medical treatment
01	51	Male	GERD, Erythematous gastritis	Stomach	G1	641	PES biopsy	6.0	Alive with regional tumor	65.6	Nil	Nil	Nil	H2 blocker
02	52	Male	Epigastralgia, Erythematous gastritis, Diarrhea	Stomach	G1	924	PES biopsy	2.0	Alive with regional tumor	111.5	Nil	Nil	Nil	Nil
03	50	Male	Epigastralgia	Stomach	G1	568	EMR	4.0	Free	127.8	Nil	Nil	Nil	Nil
04	75	Female	Epigastralgia, Erythematous gastritis	Stomach	G1	993	PES biopsy	N/A	Alive with regional tumor	27.6	N/D	N/D	N/D	Nil
05	74	Female	GERD, Gastric erosions	Stomach	G1	2878	PES biopsy	6.0	Alive with regional tumor	32.6	N/D	N/D	N/D	Nil
06	48	Female	Z-E syndrome, Diarrhea	Stomach	G1	671	Total gastrectomy	N/A	Liver recurrent	77.2	Nil	7 mm, S5/8	Nil	Nil
07	58	Female	UGI bleeding	Stomach	G1	1690	EMR	4.8	Recurrent, site unknown	80.4	Nil	Nil	Nil	H2 blocker
08	56	Female	GERD, Erythematous gastritis	Stomach	G1	1770	EMR	8.0	Regional recurrent	94.8	Nil	Nil	Nil	H2 blocker
09	43	Female	Duodenal ulcer, GERD grade A	Stomach	G1	1817	EMR	5.2	Regional recurrent	112.3	Nil	Nil	Nil	H2 blocker
10	12	Male	Diarrhea, Esophageal ulcers, Gastric ulcer	Duodenum	G3	8219	Liver biopsy PES biopsy	N/A	Expired—liver failure	9.44	Yes^a	Yes	Bone Lung	Octreotide LAR PPI Evolimus CT^c
11	35	Male	Repeat peptic ulcer, Epigastralgia	Duodenum	G1	1179	Antrectomy + Duodenectomy with lymph node resection	15.0	Alive with lymph node metastasis	26.2	Yes, Group 12	Nil	Nil	Octreotide LAR PPI
12	64	Male	Chronic gastritis	Duodenum	G1	75	EMR	5.0	Free	42.9	N/D	N/D	N/D	Nil
13	32	Male	GERD grade A Superficial gastritis, Duodenal erosions	Duodenum	G1	58	PES biopsy^e	5.0	Alive with disease (MEN-1)	48.2	Nil	Nil	Nil	Nil
14	34	Male	Epigastralgia	Duodenum and pancreas	G1	35	Subtotal gastrectomy + distal pancreatectomy^f	6.0	Alive with disease (MEN-1)	53	Yes^b	Nil	Nil	Octreotide LAR Evolimus PPI
15	39	Male	Gastric ulcers	Duodenum	NA	105	PES biopsy	8.0	Alive with regional tumor	127.3	N/D	Nil	N/D	PPI
16	25	Male	Diarrhea	Pancreas	G2	359	Liver biopsy	N/A	Expired	64	Yes	Yes	Nil	Octreotide LAR PPI Sunitinib
17	55	Female	UGI bleeding, Peptic ulcer	Duodenum	G2	nil	Liver biopsy	N/A	Expired	27.1	Yes	Yes	Yes	PPI
18	72	Female	Diarrhea, Abdominal pain	Duodenum	NA	1341	EMR	15.0	Free	80.3	Nil	Nil	Nil	PPI
19	36	Female	GERD	Duodenum and lymph node	G1	217	LN excision EMR	60.0	Free	102.1	Yes	Nil	Nil	Nil
20	33	Female	Peptic ulcer, UGI bleeding	Liver	G3	1570	Hepatectomy	150.0	Expired—liver failure	205.8	Nil	Liver origin	Bone PC	Octreotide LAR HAIC^d PPI

N/A not available, ND not done, PES panendoscopy, EMR endoscopic mucosal resection, LAR long-acting repeatable, PPI proton pump inhibitor, CT chemotherapy, HAIC hepatic arterial infusion chemotherapy, GERD Gastroesophageal reflux disease, PC Peritoneal carcinomatosis
^aMediastinal and Porta hepatis lymph nodes
^bMediastinal lymph nodes
^cChemotherapy with VP-16/Etoposide + Cisplatin/CDDP
^dHAIC with 5-FU + Cisplatin
^eSpecimen positive of gastrin and somatostatin
^fPositive of gastrin, glucagon, and insulin

Back to article page

ISSN: 1477-7819

Contact us

General enquiries: journalsubmissions@springernature.com